skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 6,364  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032
Material Type:
Article
Add to My Research

Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032

Clinical cancer research, 2021-04, Vol.27 (8), p.2179-2189 [Peer Reviewed Journal]

2021 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-20-3909 ;PMID: 33504555

Full text available

2
Exosome engineering for efficient intracellular delivery of soluble proteins using optically reversible protein-protein interaction module
Material Type:
Article
Add to My Research

Exosome engineering for efficient intracellular delivery of soluble proteins using optically reversible protein-protein interaction module

Nature communications, 2016-07, Vol.7 (1), p.12277-9, Article 12277 [Peer Reviewed Journal]

Copyright Nature Publishing Group Jul 2016 ;2016. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Copyright © 2016, Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/ncomms12277 ;PMID: 27447450

Full text available

3
Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus
Material Type:
Article
Add to My Research

Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus

Annals of the rheumatic diseases, 2016-07, Vol.75 (7), p.1407-1415 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Copyright: 2016 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2015-207776 ;PMID: 26324847 ;CODEN: ARDIAO

Full text available

4
Human resistin protects against endotoxic shock by blocking LPS–TLR4 interaction
Material Type:
Article
Add to My Research

Human resistin protects against endotoxic shock by blocking LPS–TLR4 interaction

Proceedings of the National Academy of Sciences - PNAS, 2017-11, Vol.114 (48), p.E10399-E10408 [Peer Reviewed Journal]

Volumes 1–89 and 106–114, copyright as a collective work only; author(s) retains copyright to individual articles ;Copyright National Academy of Sciences Nov 28, 2017 ;2017 ;ISSN: 0027-8424 ;ISSN: 1091-6490 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.1716015114 ;PMID: 29133417

Full text available

5
Asprosin, a Fasting-Induced Glucogenic Protein Hormone
Material Type:
Article
Add to My Research

Asprosin, a Fasting-Induced Glucogenic Protein Hormone

Cell, 2016-04, Vol.165 (3), p.566-579 [Peer Reviewed Journal]

2016 Elsevier Inc. ;Copyright © 2016 Elsevier Inc. All rights reserved. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2016.02.063 ;PMID: 27087445

Full text available

6
Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer
Material Type:
Article
Add to My Research

Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer

Journal of clinical oncology, 2015-01, Vol.33 (1), p.74-82 [Peer Reviewed Journal]

2014 by American Society of Clinical Oncology. ;2014 by American Society of Clinical Oncology 2014 ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2014.57.3329 ;PMID: 25403209

Full text available

7
Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial
Material Type:
Article
Add to My Research

Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial

The lancet oncology, 2012-10, Vol.13 (10), p.1045-1054 [Peer Reviewed Journal]

Elsevier Ltd ;2012 Elsevier Ltd ;Copyright © 2012 Elsevier Ltd. All rights reserved. ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(12)70346-7 ;PMID: 22954508 ;CODEN: LANCAO

Full text available

8
Recombinant Endolysins as Potential Therapeutics against Antibiotic-Resistant Staphylococcus aureus: Current Status of Research and Novel Delivery Strategies
Material Type:
Article
Add to My Research

Recombinant Endolysins as Potential Therapeutics against Antibiotic-Resistant Staphylococcus aureus: Current Status of Research and Novel Delivery Strategies

Clinical microbiology reviews, 2018-01, Vol.31 (1) [Peer Reviewed Journal]

Copyright © 2017 American Society for Microbiology. ;Copyright © 2017 American Society for Microbiology. 2017 American Society for Microbiology ;ISSN: 0893-8512 ;EISSN: 1098-6618 ;DOI: 10.1128/cmr.00071-17 ;PMID: 29187396

Full text available

9
Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1–2, dose-ranging study
Material Type:
Article
Add to My Research

Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1–2, dose-ranging study

The Lancet infectious diseases, 2021-09, Vol.21 (9), p.1257-1270 [Peer Reviewed Journal]

2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(21)00147-X ;PMID: 33887209

Full text available

10
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials
Material Type:
Article
Add to My Research

Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials

The Lancet (British edition), 2010-05, Vol.375 (9727), p.1695-1703 [Peer Reviewed Journal]

Elsevier Ltd ;2010 Elsevier Ltd ;Copyright 2010 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited May 15-May 21, 2010 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(10)60491-6 ;PMID: 20472172 ;CODEN: LANCAO

Full text available

11
Prion-like spreading of pathological α-synuclein in brain
Material Type:
Article
Add to My Research

Prion-like spreading of pathological α-synuclein in brain

Brain (London, England : 1878), 2013-04, Vol.136 (Pt 4), p.1128-1138 [Peer Reviewed Journal]

2014 INIST-CNRS ;The Author (2013). Published by Oxford University Press on behalf of the Guarantors of Brain. 2013 ;ISSN: 0006-8950 ;EISSN: 1460-2156 ;DOI: 10.1093/brain/awt037 ;PMID: 23466394

Full text available

12
Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial
Material Type:
Article
Add to My Research

Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2014-08, Vol.384 (9941), p.403-413 [Peer Reviewed Journal]

Elsevier Ltd ;2014 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2014 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Aug 2, 2014 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(14)60494-3 ;PMID: 24907225 ;CODEN: LANCAO

Full text available

13
Vascular endothelial growth factor: a neurovascular target in neurological diseases
Material Type:
Article
Add to My Research

Vascular endothelial growth factor: a neurovascular target in neurological diseases

Nature reviews. Neurology, 2016-08, Vol.12 (8), p.439-454 [Peer Reviewed Journal]

COPYRIGHT 2016 Nature Publishing Group ;Copyright Nature Publishing Group Aug 2016 ;ISSN: 1759-4758 ;EISSN: 1759-4766 ;DOI: 10.1038/nrneurol.2016.88 ;PMID: 27364743

Full text available

14
Phase III Prospective Randomized Comparison Trial of Depot Octreotide Plus Interferon Alfa-2b Versus Depot Octreotide Plus Bevacizumab in Patients With Advanced Carcinoid Tumors: SWOG S0518
Material Type:
Article
Add to My Research

Phase III Prospective Randomized Comparison Trial of Depot Octreotide Plus Interferon Alfa-2b Versus Depot Octreotide Plus Bevacizumab in Patients With Advanced Carcinoid Tumors: SWOG S0518

Journal of clinical oncology, 2017-05, Vol.35 (15), p.1695-1703 [Peer Reviewed Journal]

2017 by American Society of Clinical Oncology 2017 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2016.70.4072 ;PMID: 28384065

Full text available

15
Randomized, Controlled Trial of Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Intermediate-Risk Pulmonary Embolism
Material Type:
Article
Add to My Research

Randomized, Controlled Trial of Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Intermediate-Risk Pulmonary Embolism

Circulation (New York, N.Y.), 2014-01, Vol.129 (4), p.479-486 [Peer Reviewed Journal]

2014 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2015 INIST-CNRS ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.113.005544 ;PMID: 24226805 ;CODEN: CIRCAZ

Full text available

16
Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial
Material Type:
Article
Add to My Research

Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial

The Lancet (British edition), 2014-08, Vol.384 (9941), p.414-426 [Peer Reviewed Journal]

Elsevier Ltd ;2014 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2014 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Aug 2, 2014 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(14)60538-9 ;PMID: 24907224 ;CODEN: LANCAO

Full text available

17
Irisin prevents and restores bone loss and muscle atrophy in hind-limb suspended mice
Material Type:
Article
Add to My Research

Irisin prevents and restores bone loss and muscle atrophy in hind-limb suspended mice

Scientific reports, 2017-06, Vol.7 (1), p.2811-16, Article 2811 [Peer Reviewed Journal]

Copyright Nature Publishing Group Jun 2017 ;info:eu-repo/semantics/openAccess ;The Author(s) 2017 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-017-02557-8 ;PMID: 28588307

Full text available

18
Resistin, an Adipokine with Potent Proinflammatory Properties
Material Type:
Article
Add to My Research

Resistin, an Adipokine with Potent Proinflammatory Properties

The Journal of immunology (1950), 2005-05, Vol.174 (9), p.5789-5795 [Peer Reviewed Journal]

ISSN: 0022-1767 ;ISSN: 1550-6606 ;EISSN: 1550-6606 ;DOI: 10.4049/jimmunol.174.9.5789 ;PMID: 15843582

Full text available

19
The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial
Material Type:
Article
Add to My Research

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial

The Lancet (British edition), 2012-06, Vol.379 (9834), p.2352-2363 [Peer Reviewed Journal]

Elsevier Ltd ;2012 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2012 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 23-Jun 29, 2012 ;2012 Elsevier Ltd. All rights reserved. 2012 Elsevier Ltd ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(12)60768-5 ;PMID: 22632908 ;CODEN: LANCAO

Full text available

20
FGF23 induces left ventricular hypertrophy
Material Type:
Article
Add to My Research

FGF23 induces left ventricular hypertrophy

The Journal of clinical investigation, 2011-11, Vol.121 (11), p.4393-4408 [Peer Reviewed Journal]

COPYRIGHT 2011 American Society for Clinical Investigation ;COPYRIGHT 2011 American Society for Clinical Investigation ;Copyright American Society for Clinical Investigation Nov 2011 ;Copyright © 2011, American Society for Clinical Investigation 2011 ;ISSN: 0021-9738 ;EISSN: 1558-8238 ;DOI: 10.1172/JCI46122 ;PMID: 21985788

Full text available

Results 1 - 20 of 6,364  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (6,078)

Refine My Results

Creation Date 

From To
  1. Before 1991  (379)
  2. 1991 To 1998  (1,222)
  3. 1999 To 2006  (1,453)
  4. 2007 To 2015  (2,384)
  5. After 2015  (927)
  6. More options open sub menu

Language 

  1. English  (6,278)
  2. Japanese  (989)
  3. German  (28)
  4. Portuguese  (26)
  5. Spanish  (23)
  6. Russian  (11)
  7. French  (10)
  8. Serbian  (7)
  9. Chinese  (7)
  10. Italian  (4)
  11. Norwegian  (4)
  12. Turkish  (3)
  13. Dutch  (3)
  14. Polish  (2)
  15. Ukrainian  (1)
  16. Croatian  (1)
  17. Lithuanian  (1)
  18. More options open sub menu

Searching Remote Databases, Please Wait